NM_001369.3:c.6842-22A>G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001369.3(DNAH5):c.6842-22A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0436 in 1,612,932 control chromosomes in the GnomAD database, including 1,827 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.033   (  109   hom.,  cov: 33) 
 Exomes 𝑓:  0.045   (  1718   hom.  ) 
Consequence
 DNAH5
NM_001369.3 intron
NM_001369.3 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  1.16  
Publications
3 publications found 
Genes affected
 DNAH5  (HGNC:2950):  (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009] 
DNAH5 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79). 
BP6
Variant 5-13817716-T-C is Benign according to our data. Variant chr5-13817716-T-C is described in ClinVar as Benign. ClinVar VariationId is 258055.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAdExome4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0517  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| DNAH5 | ENST00000265104.5 | c.6842-22A>G | intron_variant | Intron 41 of 78 | 1 | NM_001369.3 | ENSP00000265104.4 | |||
| DNAH5 | ENST00000681290.1 | c.6797-22A>G | intron_variant | Intron 41 of 78 | ENSP00000505288.1 | |||||
| DNAH5 | ENST00000683090.1 | n.1773-22A>G | intron_variant | Intron 6 of 6 | 
Frequencies
GnomAD3 genomes  0.0335  AC: 5100AN: 152146Hom.:  109  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
5100
AN: 
152146
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0403  AC: 10118AN: 251196 AF XY:  0.0422   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
10118
AN: 
251196
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0446  AC: 65192AN: 1460668Hom.:  1718  Cov.: 30 AF XY:  0.0453  AC XY: 32938AN XY: 726686 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
65192
AN: 
1460668
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
32938
AN XY: 
726686
show subpopulations 
African (AFR) 
 AF: 
AC: 
218
AN: 
33462
American (AMR) 
 AF: 
AC: 
796
AN: 
44716
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1394
AN: 
26120
East Asian (EAS) 
 AF: 
AC: 
6
AN: 
39686
South Asian (SAS) 
 AF: 
AC: 
4570
AN: 
86194
European-Finnish (FIN) 
 AF: 
AC: 
3300
AN: 
53394
Middle Eastern (MID) 
 AF: 
AC: 
277
AN: 
5766
European-Non Finnish (NFE) 
 AF: 
AC: 
51875
AN: 
1110970
Other (OTH) 
 AF: 
AC: 
2756
AN: 
60360
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.467 
Heterozygous variant carriers
 0 
 2721 
 5442 
 8163 
 10884 
 13605 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 1894 
 3788 
 5682 
 7576 
 9470 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0335  AC: 5095AN: 152264Hom.:  109  Cov.: 33 AF XY:  0.0341  AC XY: 2535AN XY: 74436 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
5095
AN: 
152264
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
2535
AN XY: 
74436
show subpopulations 
African (AFR) 
 AF: 
AC: 
358
AN: 
41562
American (AMR) 
 AF: 
AC: 
396
AN: 
15284
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
211
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
5
AN: 
5182
South Asian (SAS) 
 AF: 
AC: 
217
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
546
AN: 
10604
Middle Eastern (MID) 
 AF: 
AC: 
6
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
3289
AN: 
68022
Other (OTH) 
 AF: 
AC: 
56
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 255 
 509 
 764 
 1018 
 1273 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 66 
 132 
 198 
 264 
 330 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
58
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 18, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.